Skip to content

Eric Van Cutsem

Universitair Ziekenhuis Leuven

2 papers in the Anchorcite directory, published between 2004 and 2013, cited 11,922 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Daniel D. Von Hoff · 1 paper
  • Thomas J. Ervin · 1 paper
  • Francis P. Arena · 1 paper
  • Elena Gabriela Chiorean · 1 paper
  • Jeffrey R. Infante · 1 paper
  • Malcolm J. Moore · 1 paper
  • Thomas E. Seay · 1 paper
  • Sergei Tjulandin · 1 paper

Papers

  1. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineNew England Journal of Medicine · 2013 · 6,853 citations

    BACKGROUND: In a phase 1-2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine, substantial clinical activity was noted in patients with advanced pancreatic cancer. We conducted a phase 3 study of the efficacy and safety of the combination versus gemcitabine monotherapy…

  2. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine · 2004 · 5,069 citations

    BACKGROUND: The epidermal growth factor receptor (EGFR), which participates in signaling pathways that are deregulated in cancer cells, commonly appears on colorectal-cancer cells. Cetuximab is a monoclonal antibody that specifically blocks the EGFR. We compared the efficacy of cetuximab in…

Metadata from OpenAlex (CC0).